Josephine Mensah

Josephine Mensah

Auto-generated profile, based on publicly available information

Josephine Mensah

Pharmacy Directorate, University of Ghana Medical Centre Ltd, Legon, Accra, Ghana

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Vaccine: X
Verified
Journal Article
Open access
CDCornelius Dodoo
Cornelius Dodoo
EHEbo Hanson-Yamoah
Ebo Hanson-Yamoah
DADavid Adedia
David Adedia
IEIrene Erzuah
Irene Erzuah
PYPeter Yamoah
Peter Yamoah
JMJosephine Mensah
Josephine Mensah
The impact of vaccine hesitancy on global health is one that carries dire consequences. This was evident during the outbreak of the COVID-19 pandemic, where numerous theories and rumours emerged. To facilitate targeted actions aimed at increasing vaccine acceptance, it is essential to identify and understand the barriers that hinder vaccine uptake, particularly regarding the COVID-19 vaccine in Ghana, one year after its introduction in the country.

15 February 2020 in Case Reports in Psychiatry
Verified
Journal Article
Open access
PDF file
MOMercy N. A. Opare-Addo
Mercy N. A. Opare-Addo
JMJosephine Mensah
Josephine Mensah
GAGrace Owusu Aboagye
Grace Owusu Aboagye
Schizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the role of clinical pharmacists in the management of a patient diagnosed with schizophrenia with symptoms of paranoia. A gainfully employed young African male adult reported to be roaming around town moving from one bank to another was arrested. The patient was referred to the psychiatric unit of a hospital and diagnosed with schizophrenia. Key interventions offered included rapid tranquilization, electroconvulsive therapy, and psychotherapy. Medications administered to the patient while on admission included IV diazepam, IM haloperidol, IV Ketamine, IM flupentixol, olanzapine tablets, and trihexyphenidyl tablets. Issues raised by clinical pharmacists during the patient’s admission included need for alternative medication for rapid tranquilization, need for initial investigations and documentation of the patient’s vitals, initiation of antipsychotic therapy without initial monitoring and screening for substance abuse, inappropriate dose at initiation of antipsychotic medications, untreated indication, and incidence of missed doses. Interventions by the clinical pharmacists contributed to improvement in the patient’s symptoms prior to hospital discharge. The case proves that it is critical for clinical pharmacists to be involved in the multidisciplinary team during management of patients with psychosis.

8 January 2026 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
JMJosephine Mensah
Josephine Mensah
AMAfia Frimpomaa Asare Marfo
Afia Frimpomaa Asare Marfo
MOMercy Naa Aduele Opare-Addo
Mercy Naa Aduele Opare-Addo
POPaul Obeng
Paul Obeng
AAAmos Amoako-Adusei
Amos Amoako-Adusei
KBKwame Ohene Buabeng
Kwame Ohene Buabeng
Objectives: To assess the current state, trends, and benefits of hydroxyurea use in sickle cell disease and identify barriers and facilitators to hydroxyurea use in sickle cell disease patients from the perspectives of patients and caregivers. Methods: A hospital-based cross-sectional study was carried out at the sickle cell disease clinic, Komfo Anokye Teaching Hospital, Ghana. A semi-structured questionnaire capturing demographics, socio-economic characteristics, medication adherence, and treatment-related factors was randomly administered to 302 participants. Data was analyzed using Chi-square tests, univariate and multivariate analysis, and ordinal logistic regression. Results: Two hundred and thirty-seven (78.5%) of the patients had SS genotype, 192 (63.58%) patients were on hydroxyurea at the time of the study. One hundred and nineteen (61.98%) patents were adherent. Decreased number of crises (132, 88.59%) and hospital admissions (78.52%) were some benefits cited by participants. However, high cost of the medication was a major challenge for a significant majority (155, 80.73%). Level of education (P = .019) was found to be significantly associated with level of adherence to hydroxyurea. Conclusion: The majority of the patients were on hydroxyurea therapy, with a significant proportion adherent to treatment. Hydroxyurea therapy was associated with a decrease in crises and hospital admissions; however, high cost remained a significant barrier to access and use while perceived benefits of hydroxyurea therapy remained facilitators to hydroxyurea use.

29 May 2026 in PLOS ONE
Verified
Journal Article
Open access
JMJosephine Mensah
Josephine Mensah
AMAfia Frimpomaa Asare Marfo
Afia Frimpomaa Asare Marfo
MOMercy Naa Aduele Opare-Addo
Mercy Naa Aduele Opare-Addo
POPaul Obeng
Paul Obeng
AAAmos Amoako-Adusei
Amos Amoako-Adusei
KBKwame Ohene Buabeng
Kwame Ohene Buabeng
Hydroxyurea is a vital medication for managing Sickle cell disease, yet access and adherence remain significant challenges in low-resource settings. This qualitative study explored challenges and opportunities in hydroxyurea access and adherence among Sickle cell disease patients at the Komfo Anokye Teaching Hospital in Ghana. Alongside, the utility of the Ahodwo CommCare mobile App in enhancing Sickle cell disease management was explored. Semi-structured interviews were conducted with six healthcare providers, including doctors, nurses, and pharmacists from May 12 to August 15, 2022. This study found that the key barriers to hydroxyurea access and adherence include financial constraints, medication stock-outs, administrative inefficiencies, bureaucratic delays, patient-related factors such as forgetfulness and concerns about side effects, and practical challenges in administering the medication especially to children. The healthcare workers indicated that reconstituting the medication into suspension added both cost and time constraints to children who cannot take capsules hence affecting access to hydroxyurea. Facilitators to access and adherence identified included patient education, streamlined procurement processes, and government support for medication subsidies. This study found that patient education sessions should emphasize the benefits of hydroxyurea treatment and the importance of adherence to prescribed regimens. The study also revealed limited awareness and utilization of the Ahodwo CommCare app among healthcare personnel, highlighting the need for targeted training and integration into clinical workflows. These findings underscore the importance of multifaceted interventions involving healthcare workers, hospital management, and government stakeholders to improve hydroxyurea access and adherence, ultimately enhancing Sickle cell disease patient outcomes.

24 February 2021 in International Journal Of Community Medicine And Public Health
Verified
Journal Article
Closed access
PDF file
MOMercy N. A. Opare-Addo
Mercy N. A. Opare-Addo
JMJosephine Mensah
Josephine Mensah
JDJanice Osei Donkor
Janice Osei Donkor
AAAmos Amoako-Adusei
Amos Amoako-Adusei
AOAngela Opoku-Bona
Angela Opoku-Bona
Background: Coronavirus Disease 2019 is a pandemic caused by a novel human coronavirus previously known as 2019-nCov. Healthcare workers are essential in the response to and management of such infectious diseases. Methods: A hospital-based cross-sectional study was conducted at Tema General Hospital, Ghana. Data was collected from healthcare workers using a structured questionnaire. Descriptive statistics was done for all socio-demographic characteristics of respondents. Level of knowledge about coronavirus disease and factors influencing participants’ willingness to work were summarized as frequencies, percentages and charts. Chi-square test was used to test for association between level of knowledge and all independent variables. Results: A total of 157 healthcare workers participated in this study. The news media (135, 85.99%) was the commonest source of information for participants. Almost half of participants (47.8%) had been tested for coronavirus disease, and 91.08% had sufficient knowledge about the disease. Occupation (p=0.047) was significantly associated with participants’ level of knowledge. A total of 46.49% disagreed with adequacy of personal protective equipment provided, with 70.06% admitting they have had to use their own personal protective equipment at work. A sense of duty (20, 31.8%) and motivation (14, 22.2%) positively influenced participants’ ability to work while challenges faced included fear of contracting and transmitting the virus (98.7%) and stigmatization (70.7%). Conclusions: The healthcare workers had sufficient knowledge about coronavirus disease. Insufficient personal protective equipment was evident during the pandemic. Measures must be established to ensure that barriers to work are eliminated while factors that enhance work output are encouraged.